Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM

Lee Jennifer Kayden sold 75,834 Rhythm Pharmaceuticals, Inc. shares (Form 4)

Traded Aug 13, 2026 · Filed Aug 14, 2026

On Aug 13, 2026, Lee Jennifer Kayden (EVP, Head of North America) sold 75,834 Rhythm Pharmaceuticals, Inc. shares at US$117.38 for US$8.9M under a trading plan, leaving 0 shares. Filed Aug 14, 2026 (Form 4).

Sold
75,834 shares
Price
US$117.38
Value
US$8.9M
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP, Head of North America

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 13, 2026Common StockOption exercise35,000US$24.2954,233Direct
Aug 13, 2026Common StockOption exercise21,601US$6.8075,834Direct
Aug 13, 2026Common StockSale75,834US$117.380Direct

Source

View original at SEC

Related